Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Li Sheng Fowler"'
Autor:
Sylvie Chabot, Yusra Gimie, Karam Obeid, Jaekwan Kim, Clement A. Meseda, Krishnamurthy Konduru, Gerardo Kaplan, Li Sheng Fowler, Jerry P. Weir, Keith Peden, Marian E. Major
Publikováno v:
J Virol
Studies on Ebola virus disease (EVD) survivors and clinical studies on Ebola virus (EBOV) vaccine candidates have pinpointed the importance of a strong antibody response in protection and survival from EBOV infection. However, little is known about t
Publikováno v:
International Journal of Biological Sciences, Vol 6, Iss 2, Pp 151-162 (2010)
Vaccines contain residual DNA derived from the cells used to produce them. As part of our investigation to assess the risk of this cellular DNA, we are developing a quantitative in vivo assay to assess the oncogenicity of DNA. In an earlier study, we
Externí odkaz:
https://doaj.org/article/58b56bd271b2476b8c04aab41af6049b
Autor:
Li Sheng-Fowler, Wei Tu, Haiqing Fu, Haruhiko Murata, Lynda Lanning, Gideon Foseh, Juliete Macauley, Donald Blair, Stephen H Hughes, John M Coffin, Andrew M Lewis, Keith Peden
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e108926 (2014)
As part of safety studies to evaluate the risk of residual cellular DNA in vaccines manufactured in tumorigenic cells, we have been developing in vivo assays to detect and quantify the oncogenic activity of DNA. We generated a plasmid expressing both
Externí odkaz:
https://doaj.org/article/3c8dc40e48fe42a784ed002171f4f82d
Publikováno v:
Vaccine. 35(41)
Development of vaccines against highly pathogenic viruses that could also be used as agents of bioterrorism is both a public health issue and a national security priority. Methods that can quantify neutralizing antibodies will likely be crucial in de
Autor:
Stephen H. Hughes, Yong Zhu, Haiqing Fu, Gideon Foseh, Li Sheng-Fowler, Keith Peden, Fang Cai, Don G. Blair, Brian Orrison, John M. Coffin, Andrew M. Lewis
Publikováno v:
International Journal of Biological Sciences
Vaccines contain residual DNA derived from the cells used to produce them. As part of our investigation to assess the risk of this cellular DNA, we are developing a quantitative in vivo assay to assess the oncogenicity of DNA. In an earlier study, we
Autor:
Donald G. Blair, Li Sheng-Fowler, Juliete Macauley, Haiqing Fu, Haruhiko Murata, Stephen H. Hughes, Keith Peden, Lynda L Lanning, John M. Coffin, Andrew M. Lewis, Wei Tu, Gideon Foseh
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e108926 (2014)
PLoS ONE
PLoS ONE
As part of safety studies to evaluate the risk of residual cellular DNA in vaccines manufactured in tumorigenic cells, we have been developing in vivo assays to detect and quantify the oncogenic activity of DNA. We generated a plasmid expressing both
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 37(4)
All viral vaccines contain contaminating residual DNA derived from the production cell substrate. The potential risk of this DNA, particularly when derived from tumorigenic cells, has been debated for over 40 years. While the major risk has been cons
Autor:
Chabot, Sylvie1, Gimie, Yusra1, Obeid, Karam1, Kim, Jaekwan1, Meseda, Clement A.1, Konduru, Krishnamurthy2, Kaplan, Gerardo2, Li Sheng Fowler1, Weir, Jerry P.1, Peden, Keith1, Major, Marian E.1 marian.major@fda.hhs.gov
Publikováno v:
Journal of Virology. 9/15/2022, Vol. 96 Issue 18, p1-13. 13p.